Eight biomarkers comprising ER, PR, HR, HER2, nm23-H1, CK5/6, EGFR, and Ki-67 were investigated for their effect on pCR outcome in Asian breast cancer patients treated with NAC TA. This evidence concerns the gene HR and breast cancer.